Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
01/09/2007 | US7160542 Method of treating psoriasis using human anti-TNF antibodies and fragments |
01/09/2007 | US7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same |
01/09/2007 | CA2269097C Synthesis and purification of hepatitis c virus-like particles |
01/09/2007 | CA2263129C Mammalian cell surface antigens; related reagents |
01/09/2007 | CA2245099C Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer |
01/09/2007 | CA2194352C Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
01/04/2007 | WO2007002571A2 Use of an anti c5 complement antibody to treat patients with sickle cell disease |
01/04/2007 | WO2007002419A1 Conformer-specific antibodies and method of use, thereof |
01/04/2007 | WO2007002223A2 Cd19 antibodies and their uses |
01/04/2007 | WO2007002069A2 Serum biomarkers for breast cancer |
01/04/2007 | WO2007001895A2 Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase |
01/04/2007 | WO2007001851A2 Compositions and methods for the diagnosis and treatment of tumor |
01/04/2007 | WO2007001817A1 Cell-based microarrays, and methods for their preparation and use |
01/04/2007 | WO2007001677A2 Compositions and methods for immunomodulation in an organism |
01/04/2007 | WO2007001422A2 High affinity antibodies against hmgb1 and methods of use thereof |
01/04/2007 | WO2007001420A2 Isolating human antibodies |
01/04/2007 | WO2007001021A1 Method for determination of enzymatic activity |
01/04/2007 | WO2007000880A1 RICE BLAST DISEASE GENE Pi21, RESISTANCE GENE pi21 AND UTILIZATION THEREOF |
01/04/2007 | WO2007000671A2 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
01/04/2007 | WO2007000328A1 Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof |
01/04/2007 | WO2006116319A3 Reagents that bind ccx-ckr2 |
01/04/2007 | WO2006073493A3 Vaccine conjugates comprising a monoclonal antibody binding to human dentritic cells and beta human chronic gonadotropin |
01/04/2007 | WO2006071250A3 Soluble fragments of the sars-cov spike glycoprotein |
01/04/2007 | WO2006063150A3 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
01/04/2007 | WO2006060265A3 Methods and systems for prognosis and treatment of solid tumors |
01/04/2007 | WO2006059106A3 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
01/04/2007 | WO2006042313A3 Egfr antagonist in treatment of fluid accumulation |
01/04/2007 | WO2006038027A3 SINGLE DOMAIN ANTIBODIES AGAINST TNFRl AND METHODS OF USE THEREFOR |
01/04/2007 | WO2006033702A3 Anti-cd154 antibodies |
01/04/2007 | WO2006029369A3 Methods and compositions for measuring natriuretic peptides and uses thereof |
01/04/2007 | WO2006014729A3 Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
01/04/2007 | WO2005110474A3 HUMANIZED FcϜRIIB SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
01/04/2007 | WO2005110039A3 Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof |
01/04/2007 | WO2005035572A3 Antibody compositions and methods |
01/04/2007 | WO2005033275A3 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
01/04/2007 | US20070004913 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
01/04/2007 | US20070004910 Human tissue kallikreins; asthma, chronic obstructive pulmonary disease (COPD), multiple sclerosis, psoriasis, rheumatoid arthritis, osteopathic arthritis, osteoarthritis, rhinitis, sinusitus, inflammatory bowel diseases (such as Crohn's disease and ulcerative colitis), immune mediated diabetes |
01/04/2007 | US20070004909 Covalent diabodies and uses thereof |
01/04/2007 | US20070004904 G-csf conjugates |
01/04/2007 | US20070004630 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
01/04/2007 | US20070004015 Novel metabolism-associated gene products from ashbya gossypii |
01/04/2007 | US20070004008 Human ccv polypeptides |
01/04/2007 | US20070004007 Peptide consisting tumor necrosis factor alpha converting enzyme protease inhibitor; growth hormone related disease; Alzheimer's disease; used to induce apoptosis of cancer cells |
01/04/2007 | US20070003991 Method of diagnosing Lawsonia intracellularis |
01/04/2007 | US20070003990 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
01/04/2007 | US20070003985 Specific mucin expression as a marker for pancreatic cancer |
01/04/2007 | US20070003982 Analyzing nerve cell damage |
01/04/2007 | US20070003978 Immunological assay for spongiform encephalopathies |
01/04/2007 | US20070003974 Cene-E biopolymer marker indicative of age matched control |
01/04/2007 | US20070003972 Detection and treatment of cancers of the lung |
01/04/2007 | US20070003971 Determining the identity of biallelic markers at a particular position of a FLAP gene and using that information to evaluate whether an individual is at increased risk of asthma |
01/04/2007 | US20070003969 Screening for cancer by detecting nucleic acid encoding erythropoietin receptor isoform 2 |
01/04/2007 | US20070003574 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis |
01/04/2007 | US20070003573 Viral expression vector for use in the treatment and diagnosis of viral, cardiovascular, nervous system and metabolic disorders |
01/04/2007 | US20070003569 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis |
01/04/2007 | US20070003568 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
01/04/2007 | US20070003562 Chimera molecule containing protein and merozoites surface protein; induce immunology response against antigen |
01/04/2007 | US20070003561 Binding member towards pneumococcus surface adhesin a protein (psaa) |
01/04/2007 | US20070003560 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
01/04/2007 | US20070003555 Heat shock protein binding fragments of CD91, and uses thereof |
01/04/2007 | US20070003553 Anticoagulant agents useful in treatment of thrombosis |
01/04/2007 | US20070003551 Immunoglobulin |
01/04/2007 | US20070003549 treatment and prevention of cell proliferative and inflammatory disorders; drug delivery device is for simultaneously administering to a subject anti-VEGF treatment and anti-EGFR treatment |
01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
01/04/2007 | US20070003547 Super humanized antibodies |
01/04/2007 | US20070003546 engineered glycoform; improved therapeutic properties, reduced risk of immunogenicity, enabling for the alternate production methods |
01/04/2007 | US20070003545 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
01/04/2007 | US20070003535 Methods and compositions for derepression of IAP-inhibited caspase |
01/04/2007 | US20070003519 reducing ICT1024 expression; inhibitor is an siRNA, shRNA, antisense RNA, antisense DNA, decoy molecule, decoy DNA, double stranded DNA, single-stranded DNA, complexed DNA, encapsulated DNA, viral DNA, plasmid DNA, naked RNA, encapsulated RNA, viral RNA, double stranded RNA, RNA interference; cancer |
01/04/2007 | US20070003514 Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination |
01/04/2007 | US20070003482 Ultrasound contrast agents for molecular imaging |
01/04/2007 | CA2613512A1 Antibody formulations having optimized aggregation and fragmentation profiles |
01/04/2007 | CA2613193A1 Thrombospondin-1 derived peptides and treatment methods |
01/04/2007 | CA2612760A1 Il-1.beta. binding antibodies and fragments thereof |
01/04/2007 | CA2612486A1 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
01/04/2007 | CA2612378A1 Methods and compositions for targeting ifnar2 |
01/04/2007 | CA2611814A1 Cd19 antibodies and their uses |
01/04/2007 | CA2608474A1 Compositions and methods for immunomodulation in an organism |
01/04/2007 | CA2585043A1 High affinity antibodies against hmgb1 and methods of use thereof |
01/03/2007 | EP1739177A1 Antibodies against interferon alpha/beta receptor |
01/03/2007 | EP1739171A1 Novel gene participating in epidermal differentiation and use thereof |
01/03/2007 | EP1737983A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
01/03/2007 | EP1737973A1 Truncated adamts molecules |
01/03/2007 | EP1737971A2 Mixtures of binding proteins |
01/03/2007 | EP1737969A2 Production of galactosylated glycoproteins in lower eukaryotes |
01/03/2007 | EP1737963A1 Use of a gene coding for the c4bp protein beta chain for producing recombinant dimeric proteins |
01/03/2007 | EP1737961A1 Modified bouganin proteins, cytotoxins and methods and uses thereof |
01/03/2007 | EP1737958A1 Compositions and methods for inducing anti-tumor immunity |
01/03/2007 | EP1737891A1 Anti-p-selectin antibodies |
01/03/2007 | EP1737890A2 Immunoglobulin variants outside the fc region |
01/03/2007 | EP1737491A2 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS |
01/03/2007 | EP1737490A2 Methods of treating autoimmune and inflammatory diseases |
01/03/2007 | EP1737489A2 ErbB ANTAGONISTS FOR PAIN THERAPY |
01/03/2007 | EP1737488A1 Treatment of fungal infections |
01/03/2007 | EP1737487A1 Method for treating autoimmune diseases with antibodies |
01/03/2007 | EP1685245A4 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
01/03/2007 | EP1585539A4 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
01/03/2007 | EP1572900A4 Antibodies directed to pdgfd and uses thereof |